BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 32220613)

  • 21. A microbial signature for Crohn's disease.
    Pascal V; Pozuelo M; Borruel N; Casellas F; Campos D; Santiago A; Martinez X; Varela E; Sarrabayrouse G; Machiels K; Vermeire S; Sokol H; Guarner F; Manichanh C
    Gut; 2017 May; 66(5):813-822. PubMed ID: 28179361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A modular organization of the human intestinal mucosal microbiota and its association with inflammatory bowel disease.
    Tong M; Li X; Wegener Parfrey L; Roth B; Ippoliti A; Wei B; Borneman J; McGovern DP; Frank DN; Li E; Horvath S; Knight R; Braun J
    PLoS One; 2013; 8(11):e80702. PubMed ID: 24260458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic interleukin-9 in inflammatory bowel disease: Association with mucosal healing in ulcerative colitis.
    Matusiewicz M; Neubauer K; Bednarz-Misa I; Gorska S; Krzystek-Korpacka M
    World J Gastroenterol; 2017 Jun; 23(22):4039-4046. PubMed ID: 28652656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis.
    Bajer L; Kverka M; Kostovcik M; Macinga P; Dvorak J; Stehlikova Z; Brezina J; Wohl P; Spicak J; Drastich P
    World J Gastroenterol; 2017 Jul; 23(25):4548-4558. PubMed ID: 28740343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of Crohn's disease related polymorphisms in innate immune function on ileal microbiome.
    Li E; Zhang Y; Tian X; Wang X; Gathungu G; Wolber A; Shiekh SS; Sartor RB; Davidson NO; Ciorba MA; Zhu W; Nelson LM; Robertson CE; Frank DN
    PLoS One; 2019; 14(2):e0213108. PubMed ID: 30818349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Visceral adiposity and inflammatory bowel disease.
    Rowan CR; McManus J; Boland K; O'Toole A
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bacterial Mucosa-associated Microbiome in Inflamed and Proximal Noninflamed Ileum of Patients With Crohn's Disease.
    Olaisen M; Flatberg A; Granlund AVB; Røyset ES; Martinsen TC; Sandvik AK; Fossmark R
    Inflamm Bowel Dis; 2021 Jan; 27(1):12-24. PubMed ID: 32448900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional Characterization of Inflammatory Bowel Disease-Associated Gut Dysbiosis in Gnotobiotic Mice.
    Nagao-Kitamoto H; Shreiner AB; Gillilland MG; Kitamoto S; Ishii C; Hirayama A; Kuffa P; El-Zaatari M; Grasberger H; Seekatz AM; Higgins PD; Young VB; Fukuda S; Kao JY; Kamada N
    Cell Mol Gastroenterol Hepatol; 2016 Jul; 2(4):468-481. PubMed ID: 27795980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Definition and evaluation of mucosal healing in clinical practice.
    Mazzuoli S; Guglielmi FW; Antonelli E; Salemme M; Bassotti G; Villanacci V
    Dig Liver Dis; 2013 Dec; 45(12):969-77. PubMed ID: 23932331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two-Sample Mendelian Randomization Analysis Investigates Causal Associations Between Gut Microbial Genera and Inflammatory Bowel Disease, and Specificity Causal Associations in Ulcerative Colitis or Crohn's Disease.
    Liu B; Ye D; Yang H; Song J; Sun X; Mao Y; He Z
    Front Immunol; 2022; 13():921546. PubMed ID: 35860271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disease-Specific Enteric Microbiome Dysbiosis in Inflammatory Bowel Disease.
    Mirsepasi-Lauridsen HC; Vrankx K; Engberg J; Friis-Møller A; Brynskov J; Nordgaard-Lassen I; Petersen AM; Krogfelt KA
    Front Med (Lausanne); 2018; 5():304. PubMed ID: 30525037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased abundance of proteobacteria in aggressive Crohn's disease seven years after diagnosis.
    Vester-Andersen MK; Mirsepasi-Lauridsen HC; Prosberg MV; Mortensen CO; Träger C; Skovsen K; Thorkilgaard T; Nøjgaard C; Vind I; Krogfelt KA; Sørensen N; Bendtsen F; Petersen AM
    Sci Rep; 2019 Sep; 9(1):13473. PubMed ID: 31530835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Siblings of patients with Crohn's disease exhibit a biologically relevant dysbiosis in mucosal microbial metacommunities.
    Hedin C; van der Gast CJ; Rogers GB; Cuthbertson L; McCartney S; Stagg AJ; Lindsay JO; Whelan K
    Gut; 2016 Jun; 65(6):944-53. PubMed ID: 25856344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis of Crohn's disease and ulcerative colitis using the microbiome.
    Kang DY; Park JL; Yeo MK; Kang SB; Kim JM; Kim JS; Kim SY
    BMC Microbiol; 2023 Nov; 23(1):336. PubMed ID: 37951857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of Flagellin-Specific Adaptive Immunity Reveals Links to Dysbiosis in Patients With Inflammatory Bowel Disease.
    Cook L; Lisko DJ; Wong MQ; Garcia RV; Himmel ME; Seidman EG; Bressler B; Levings MK; Steiner TS
    Cell Mol Gastroenterol Hepatol; 2020; 9(3):485-506. PubMed ID: 31790809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between clinical features and intestinal microbiota in Chinese patients with ulcerative colitis.
    He XX; Li YH; Yan PG; Meng XC; Chen CY; Li KM; Li JN
    World J Gastroenterol; 2021 Jul; 27(28):4722-4737. PubMed ID: 34366632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Markers of dysbiosis in patients with ulcerative colitis and Crohn's disease.
    Danilova NA; Abdulkhakov SR; Grigoryeva TV; Markelova MI; Vasilyev IY; Boulygina EA; Ardatskaya MD; Pavlenko AV; Tyakht AV; Odintsova AK; Abdulkhakov RA
    Ter Arkh; 2019 May; 91(4):17-24. PubMed ID: 31094471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC.
    Ferrante M; Colombel JF; Sandborn WJ; Reinisch W; Mantzaris GJ; Kornbluth A; Rachmilewitz D; Lichtiger S; D'Haens GR; van der Woude CJ; Danese S; Diamond RH; Oortwijn AF; Tang KL; Miller M; Cornillie F; Rutgeerts PJ;
    Gastroenterology; 2013 Nov; 145(5):978-986.e5. PubMed ID: 23954314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel Diseases.
    Nikolaus S; Schulte B; Al-Massad N; Thieme F; Schulte DM; Bethge J; Rehman A; Tran F; Aden K; Häsler R; Moll N; Schütze G; Schwarz MJ; Waetzig GH; Rosenstiel P; Krawczak M; Szymczak S; Schreiber S
    Gastroenterology; 2017 Dec; 153(6):1504-1516.e2. PubMed ID: 28827067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mucosa-Associated Ileal Microbiota in New-Onset Pediatric Crohn's Disease.
    Assa A; Butcher J; Li J; Elkadri A; Sherman PM; Muise AM; Stintzi A; Mack D
    Inflamm Bowel Dis; 2016 Jul; 22(7):1533-9. PubMed ID: 27271491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.